Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of refractory anaphylaxis
Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning...
Saved in:
Published in | The World Allergy Organization journal Vol. 17; no. 8; p. 100944 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.08.2024
Elsevier BV Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 1939-4551 1939-4551 |
DOI | 10.1016/j.waojou.2024.100944 |
Cover
Abstract | Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis.
We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis.
One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis.
Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis. |
---|---|
AbstractList | Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis.
We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis.
One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (
= 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (
< 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%,
= 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%,
< 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87-12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86-11.41) were independently associated with refractory anaphylaxis.
Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis. Background: Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. Methods: We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. Results: One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Conclusion: Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis. Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis. Background Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis. Methods We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis. Results One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) ( P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) ( P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87–12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86–11.41) were independently associated with refractory anaphylaxis. Conclusion Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis. Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis.BackgroundRefractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM) adrenaline injections. Studies on the association of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) concerning anaphylactic severity have yet to be carried out. The study aimed to evaluate the association between blood PLR and NLR levels and refractory anaphylaxis.We carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis.MethodsWe carried out a retrospective cross-sectional study in which medical records of patients with anaphylaxis who sought urgent care at the Emergency Department (ED) of Tertiary Hospital in Hanoi, Vietnam, were evaluated. Based on the United Kingdom Resuscitation Council guidelines in 2021, patients were classified as refractory anaphylaxis if they needed more than two appropriate doses of intramuscular adrenaline for anaphylactic symptoms resolution. Clinical data and laboratory results were obtained in the medical records. Logistic regression analysis determined the association between contributing factors and refractory anaphylaxis.One-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87-12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86-11.41) were independently associated with refractory anaphylaxis.ResultsOne-hundred eighteen adults (age 51.80 ± 18.25 years) were analyzed, including 38 refractory anaphylaxis patients (32.2%). Refractory anaphylaxis patients exhibited notably elevated platelet-to-lymphocyte ratio (PLR) (P = 0.006) and increased neutrophil-to-lymphocyte ratio (NLR) (P < 0.001) in comparison to non-refractory anaphylaxis patients. Receiver operating characteristic curve (ROC) analysis demonstrated an optimal PLR cutoff value of 129.5 (area under the ROC curve [AUC] 0.658, sensitivity 73.68%, specificity 61.25%, P = 0.004) and an optimal NLR cutoff value of 4 (AUC 0.736, sensitivity 65.79%, specificity 73.75%, P < 0.001) for refractory anaphylaxis. Multivariate logistic regression analysis revealed a PLR≥129.5 (OR = 4.83, 95% CI: 1.87-12.48) and an NLR≥4 (OR = 4.60, 95% CI: 1.86-11.41) were independently associated with refractory anaphylaxis.Elevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis.ConclusionElevated PLR and NLR serve as independent indicators significantly associated with refractory anaphylaxis. |
ArticleNumber | 100944 |
Author | Nghi, Le Vinh Hai, Pham Dang Phuc, Nguyen Hoang |
Author_xml | – sequence: 1 givenname: Le Vinh surname: Nghi fullname: Nghi, Le Vinh organization: College of Health Sciences, VinUniversity, Ha Noi, Viet Nam – sequence: 2 givenname: Nguyen Hoang surname: Phuc fullname: Phuc, Nguyen Hoang organization: College of Health Sciences, VinUniversity, Ha Noi, Viet Nam – sequence: 3 givenname: Pham Dang orcidid: 0000-0001-9300-231X surname: Hai fullname: Hai, Pham Dang email: bsphamdanghai@gmail.com organization: Medical Intensive Care Unit, 108 Military Central Hospital, Viet Nam |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39220464$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkluL1TAUhYuMOBf9ByIFX3zpMdemFRFk8DIwoA_6HNJkd06OOU1NUsf-e1M7DnIQjk9JNmutvdlfzouTwQ9QFE8x2mCE65e7za3yOz9tCCIsl1DL2IPiDLe0rRjn-OSv-2lxHuMOoRphTh8Vp7QlBLGanRU3n51K4CBVyVdu3o9br-cEZVDJ-lINphxgSsGPW-v-LYnlGMBYnXyIpe_LAH1Qy2vOdjVuZ6d-2vi4eNgrF-HJ3XlRfH3_7svlx-r604ery7fXleacpwoDJg0ztcHQk5ZTrLHWnRGia3EnEFaKQJ9LFDMjeI9J3bekrhvaiMb0APSiuFpzjVc7OQa7V2GWXln5u-DDjVQhWe1ANhwQ7jnRvaLMENHoZYmdgboRgpomZ_E1axpGNd8q5-4DMZILBLmTKwS5QJArhOx7sfrG4L9PEJPc26jBOTWAn6KkqG0b3jC8tHh-IM1hYcgbkhSLVojMrM6qZ3eqqduDuZ_iD8YsYKtABx9jJvC_g746sGmbFqpDCsq6Y-Y3qxkyzh8WgozawqDzXwigU963PRbw-iBAOztYrdw3mI_bfwFKofEm |
CitedBy_id | crossref_primary_10_1016_j_ajem_2025_03_017 |
Cites_doi | 10.1016/S0091-6749(99)70107-7 10.1111/ijcp.14655 10.7861/clinmed.2022-0073 10.1002/biof.1956 10.1016/j.jcrc.2021.12.005 10.1016/j.jaci.2004.04.029 10.1016/j.eimc.2020.11.004 10.1111/cea.12418 10.1159/000509116 10.1016/j.waojou.2019.100066 10.1016/j.jaip.2019.11.027 10.1007/s00405-019-05640-0 10.1111/j.1398-9995.2012.02795.x 10.1111/cea.12868 10.1016/j.jaci.2015.06.052 10.1136/bmj.39339.610000.BE 10.1016/j.jaci.2017.06.003 10.1189/jlb.1212623 10.2500/108854199778251834 10.1016/j.micinf.2014.07.004 10.3390/biomedicines10010075 10.1016/j.jaci.2015.04.019 10.1016/j.anai.2018.11.029 10.1016/j.jaci.2012.08.016 10.1155/2015/429534 10.1016/j.waojou.2020.100472 10.1186/s13223-021-00512-x 10.1016/j.alit.2017.05.005 10.1016/0167-5699(87)90010-7 10.1016/S1081-1206(10)61367-1 |
ContentType | Journal Article |
Copyright | 2024 The Authors 2024 The Authors. 2024. The Authors |
Copyright_xml | – notice: 2024 The Authors – notice: 2024 The Authors. – notice: 2024. The Authors |
DBID | 6I. AAFTH AAYXX CITATION NPM K9. NAPCQ 7X8 ADTOC UNPAY DOA |
DOI | 10.1016/j.waojou.2024.100944 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-4551 |
ExternalDocumentID | oai_doaj_org_article_85e01f52cfa34d278c1009bde68773d8 10.1016/j.waojou.2024.100944 39220464 10_1016_j_waojou_2024_100944 S1939455124000759 |
Genre | Journal Article |
GeographicLocations | United States--US Vietnam |
GeographicLocations_xml | – name: Vietnam – name: United States--US |
GroupedDBID | --- .1- .FO 08G 0R~ 123 4.4 53G 5VS 7RV 7X7 8C1 8FI 8FJ AAEDW AAKAS AAKDD AALRI AAXUO AAYWO ABMAC ABUWG ACGFS ACIHN ACVFH ADBBV ADBIZ ADCNI ADRAZ ADUKV ADVLN ADZCM AEAQA AEUPX AEXQZ AFJKZ AFKRA AFPUW AFRHN AFTJW AFTRI AHBYD AHMBA AHSBF AHYZX AIGII AITUG AIZYK AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMKLP AMRAJ AOIJS APXCP AQUVI ASPBG AVWKF BCNDV BENPR BFQNJ BKEYQ BMC BPHCQ BVXVI C6C CCPQU CS3 EBS EJD EX3 FDB FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE HZ~ IAO IHR IPNFZ ITC KD2 KQ8 M0T M41 M48 M~E NAPCQ NTWIH O9- OK1 OVD P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PUEGO RBZ RIG RNS ROL RPM RSV SOJ SSZ TEORI UKHRP V2I W3M WOQ WOW Z5R -A0 0SF 3V. 6I. AACTN AAFTH ACRMQ ADINQ ALIPV C24 IHW NCXOZ AAYXX CITATION NPM K9. 7X8 ADTOC UNPAY |
ID | FETCH-LOGICAL-c555t-1e1284d6d1ef29531c1ccbd77b91b701aa2ef1cc314d75f126f926683878dfee3 |
IEDL.DBID | UNPAY |
ISSN | 1939-4551 |
IngestDate | Wed Aug 27 01:04:41 EDT 2025 Wed Aug 20 00:10:57 EDT 2025 Thu Sep 04 23:01:57 EDT 2025 Sat Aug 23 12:53:52 EDT 2025 Mon Jul 21 05:58:43 EDT 2025 Thu Apr 24 22:57:34 EDT 2025 Wed Oct 01 05:05:01 EDT 2025 Sat Aug 31 16:01:07 EDT 2024 Tue Aug 26 16:32:46 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Platelet-to-lymphocyte ratio Anaphylaxis Neutrophil-to-lymphocyte ratio Adrenaline Refractory anaphylaxis |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. 2024 The Authors. cc-by-nc-nd |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c555t-1e1284d6d1ef29531c1ccbd77b91b701aa2ef1cc314d75f126f926683878dfee3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9300-231X |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://doi.org/10.1016/j.waojou.2024.100944 |
PMID | 39220464 |
PQID | 3179770066 |
PQPubID | 2040184 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_85e01f52cfa34d278c1009bde68773d8 unpaywall_primary_10_1016_j_waojou_2024_100944 proquest_miscellaneous_3099858418 proquest_journals_3179770066 pubmed_primary_39220464 crossref_primary_10_1016_j_waojou_2024_100944 crossref_citationtrail_10_1016_j_waojou_2024_100944 elsevier_sciencedirect_doi_10_1016_j_waojou_2024_100944 elsevier_clinicalkey_doi_10_1016_j_waojou_2024_100944 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2024 2024-08-00 2024-Aug 20240801 2024-08-01 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 08 year: 2024 text: August 2024 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Milwaukee |
PublicationTitle | The World Allergy Organization journal |
PublicationTitleAlternate | World Allergy Organ J |
PublicationYear | 2024 |
Publisher | Elsevier Inc Elsevier BV Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier BV – name: Elsevier |
References | Tien (bib12) 2017 Jentzer, Szekely, Burstein (bib30) 2022; 68 Francis, Bosio, Stone (bib26) 2017; 47 Drăgoescu, Pădureanu, Stănculescu (bib33) 2021; 10 Braquet, Rola-Pleszcynski (bib18) 1987; 8 Kim, Choi, Park (bib5) 2021; 17 Huang, Huang, Zhan (bib20) 2020; 24 Gill, Jindal, Jagdis, Vadas (bib17) 2015; 135 Mochimaru, Ueda, Suzuki, Asano, Fukunaga (bib27) 2019; 122 Reber, Hernandez, Galli (bib23) 2017; 140 Tian, Zhou, Xia, Shen, Ying (bib16) 2014; 16 Sasmita, Zhu, Gan (bib32) 2021; 75 Whyte, Soar, Dodd, Hughes, Sargant, Turner (bib4) 2022; 22 Kim, Kim, Cho (bib22) 2018; 67 Branicka, Rogala, Glück (bib8) 2020; 181 Pruc, Peacock, Rafique (bib31) 2023; 12 Brown (bib10) 2004; 114 Francuzik, Nassiri, Babina, Worm (bib29) 2015; 136 Worm, Edenharter, Ruëff (bib25) 2012; 67 Wang, Mivefroshan, Yaghoobpoor (bib35) 2022; 2022 Tang, Xu, Cao (bib21) 2015; 2015 Webb, Lieberman (bib28) 2006; 97 Esmaeilzadeh, Nouri, Nabavizadeh, Alyasin, Mortazavi (bib6) 2021; 17 Turner, Campbell, Motosue, Campbell (bib3) 2020; 8 Korenblat, Lundie, Dankner, Day (bib13) 1999; 20 Goodyear, Krleza-Jeric, Lemmens (bib11) 2007; 335 Lorente, Martín, Ortiz-López (bib34) 2022; 40 Göker, Ekincioglu, Alagöz (bib7) 2019; 276 Jönsson, Mancardi, Albanesi, Bruhns (bib24) 2013; 94 Turner, Worm, Ansotegui (bib9) 2019; 12 Vadas, Perelman, Liss (bib19) 2013; 131 Ohta, Yamashita (bib15) 1999; 104 Cardona, Ansotegui, Ebisawa (bib1) 2020; 13 Tejedor Alonso, Moro Moro, Múgica García (bib2) 2015; 45 Pałgan, Tretyn (bib14) 2023; 49 Turner (10.1016/j.waojou.2024.100944_bib9) 2019; 12 Turner (10.1016/j.waojou.2024.100944_bib3) 2020; 8 Tang (10.1016/j.waojou.2024.100944_bib21) 2015; 2015 Brown (10.1016/j.waojou.2024.100944_bib10) 2004; 114 Gill (10.1016/j.waojou.2024.100944_bib17) 2015; 135 Whyte (10.1016/j.waojou.2024.100944_bib4) 2022; 22 Korenblat (10.1016/j.waojou.2024.100944_bib13) 1999; 20 Mochimaru (10.1016/j.waojou.2024.100944_bib27) 2019; 122 Göker (10.1016/j.waojou.2024.100944_bib7) 2019; 276 Cardona (10.1016/j.waojou.2024.100944_bib1) 2020; 13 Francis (10.1016/j.waojou.2024.100944_bib26) 2017; 47 Drăgoescu (10.1016/j.waojou.2024.100944_bib33) 2021; 10 Tejedor Alonso (10.1016/j.waojou.2024.100944_bib2) 2015; 45 Tian (10.1016/j.waojou.2024.100944_bib16) 2014; 16 Kim (10.1016/j.waojou.2024.100944_bib22) 2018; 67 Huang (10.1016/j.waojou.2024.100944_bib20) 2020; 24 Esmaeilzadeh (10.1016/j.waojou.2024.100944_bib6) 2021; 17 Jentzer (10.1016/j.waojou.2024.100944_bib30) 2022; 68 Worm (10.1016/j.waojou.2024.100944_bib25) 2012; 67 Kim (10.1016/j.waojou.2024.100944_bib5) 2021; 17 Jönsson (10.1016/j.waojou.2024.100944_bib24) 2013; 94 Tien (10.1016/j.waojou.2024.100944_bib12) 2017 Francuzik (10.1016/j.waojou.2024.100944_bib29) 2015; 136 Goodyear (10.1016/j.waojou.2024.100944_bib11) 2007; 335 Pałgan (10.1016/j.waojou.2024.100944_bib14) 2023; 49 Reber (10.1016/j.waojou.2024.100944_bib23) 2017; 140 Pruc (10.1016/j.waojou.2024.100944_bib31) 2023; 12 Wang (10.1016/j.waojou.2024.100944_bib35) 2022; 2022 Branicka (10.1016/j.waojou.2024.100944_bib8) 2020; 181 Ohta (10.1016/j.waojou.2024.100944_bib15) 1999; 104 Webb (10.1016/j.waojou.2024.100944_bib28) 2006; 97 Braquet (10.1016/j.waojou.2024.100944_bib18) 1987; 8 Vadas (10.1016/j.waojou.2024.100944_bib19) 2013; 131 Lorente (10.1016/j.waojou.2024.100944_bib34) 2022; 40 Sasmita (10.1016/j.waojou.2024.100944_bib32) 2021; 75 |
References_xml | – volume: 131 start-page: 144 year: 2013 end-page: 149 ident: bib19 article-title: Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis publication-title: J Allergy Clin Immunol – volume: 67 start-page: 96 year: 2018 end-page: 102 ident: bib22 article-title: Different clinical features of anaphylaxis according to cause and risk factors for severe reactions publication-title: Allergol Int – volume: 16 start-page: 811 year: 2014 end-page: 821 ident: bib16 article-title: Balance of apoptotic cell death and survival in allergic diseases publication-title: Microb Infect – volume: 67 start-page: 691 year: 2012 end-page: 698 ident: bib25 article-title: Symptom profile and risk factors of anaphylaxis in Central Europe publication-title: Allergy – volume: 8 start-page: 345 year: 1987 end-page: 351 ident: bib18 article-title: Platelet-activating factor and cellular immune responses publication-title: Immunol Today – volume: 2015 year: 2015 ident: bib21 article-title: Clinical characteristics of inpatients with anaphylaxis in China publication-title: BioMed Res Int – volume: 22 start-page: 332 year: 2022 end-page: 339 ident: bib4 article-title: Emergency treatment of anaphylaxis: concise clinical guidance publication-title: Clin Med – volume: 40 start-page: 235 year: 2022 end-page: 240 ident: bib34 article-title: Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality publication-title: Enferm Infecc Microbiol Clín – volume: 24 start-page: 11719 year: 2020 end-page: 11728 ident: bib20 article-title: The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: a systematic review and meta-analysis publication-title: Eur Rev Med Pharmacol Sci – volume: 181 start-page: 774 year: 2020 end-page: 782 ident: bib8 article-title: Eosinophil/Neutrophil/Platelet-to-Lymphocyte ratios in various types of immediate hypersensitivity to NSAIDs: a preliminary study publication-title: Int Arch Allergy Immunol – volume: 13 year: 2020 ident: bib1 article-title: World allergy organization anaphylaxis guidance 2020 publication-title: World Allergy Organization Journal – volume: 136 start-page: 1425 year: 2015 ident: bib29 article-title: Impact of sex on anaphylaxis severity—data from the Anaphylaxis Registry publication-title: J Allergy Clin Immunol – volume: 45 start-page: 1027 year: 2015 end-page: 1039 ident: bib2 article-title: Epidemiology of anaphylaxis publication-title: Clin Exp Allergy – volume: 12 start-page: 6903 year: 2023 ident: bib31 article-title: The prognostic role of platelet-to-lymphocyte ratio in acute coronary syndromes: a systematic review and meta-analysis publication-title: J Clin Med – volume: 10 start-page: 75 year: 2021 ident: bib33 article-title: Neutrophil to lymphocyte ratio (NLR)-A useful tool for the prognosis of sepsis in the ICU publication-title: Biomedicines – volume: 17 start-page: 16 year: 2021 ident: bib6 article-title: Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation? Allergy publication-title: Asthma & Clinical Immunology – year: 2017 ident: bib12 article-title: Guidelines on Prevention, Diagosis and Management of Anaphylaxis – volume: 97 start-page: 39 year: 2006 end-page: 43 ident: bib28 article-title: Anaphylaxis: a review of 601 cases publication-title: Ann Allergy Asthma Immunol – volume: 135 start-page: 1424 year: 2015 end-page: 1432 ident: bib17 article-title: Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis publication-title: J Allergy Clin Immunol – volume: 114 start-page: 371 year: 2004 end-page: 376 ident: bib10 article-title: Clinical features and severity grading of anaphylaxis publication-title: J Allergy Clin Immunol – volume: 2022 year: 2022 ident: bib35 article-title: Prognostic value of platelet to lymphocyte ratio in sepsis: a systematic review and meta-analysis publication-title: BioMed Res Int – volume: 94 start-page: 643 year: 2013 end-page: 656 ident: bib24 article-title: Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions publication-title: J Leukoc Biol – volume: 276 start-page: 3383 year: 2019 end-page: 3388 ident: bib7 article-title: The association of allergic rhinitis severity with neutrophil–lymphocyte and platelet–lymphocyte ratio in adults publication-title: Eur Arch Oto-Rhino-Laryngol – volume: 75 year: 2021 ident: bib32 article-title: Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: a cohort study publication-title: Int J Clin Pract – volume: 335 start-page: 624 year: 2007 end-page: 625 ident: bib11 article-title: The declaration of Helsinki publication-title: BMJ – volume: 104 start-page: 14 year: 1999 end-page: 21 ident: bib15 article-title: Apoptosis of eosinophils and lymphocytes in allergic inflammation publication-title: J Allergy Clin Immunol – volume: 122 start-page: 337 year: 2019 end-page: 339.e1 ident: bib27 article-title: Neutrophil-to-lymphocyte ratio as a novel independent predictor of severe exacerbation in patients with asthma publication-title: Ann Allergy Asthma Immunol – volume: 49 start-page: 976 year: 2023 end-page: 983 ident: bib14 article-title: Platelet-activating factor as an endogenous cofactor of food anaphylaxis publication-title: Biofactors – volume: 12 year: 2019 ident: bib9 article-title: Time to revisit the definition and clinical criteria for anaphylaxis? publication-title: World Allergy Organization Journal – volume: 8 start-page: 1169 year: 2020 end-page: 1176 ident: bib3 article-title: Global trends in anaphylaxis epidemiology and clinical implications publication-title: J Allergy Clin Immunol Pract – volume: 140 start-page: 335 year: 2017 end-page: 348 ident: bib23 article-title: The pathophysiology of anaphylaxis publication-title: J Allergy Clin Immunol – volume: 17 start-page: 158 year: 2021 end-page: 166 ident: bib5 article-title: The association between neutrophil-to-lymphocyte ratio and anaphylaxis refractory to epinephrine treatment publication-title: Signa Vitae – volume: 47 start-page: 361 year: 2017 end-page: 370 ident: bib26 article-title: Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62L publication-title: Clin Exp Allergy – volume: 68 start-page: 50 year: 2022 end-page: 58 ident: bib30 article-title: Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity publication-title: J Crit Care – volume: 20 start-page: 383 year: 1999 end-page: 386 ident: bib13 article-title: A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed? publication-title: Allergy Asthma Proc – volume: 104 start-page: 14 issue: 1 year: 1999 ident: 10.1016/j.waojou.2024.100944_bib15 article-title: Apoptosis of eosinophils and lymphocytes in allergic inflammation publication-title: J Allergy Clin Immunol doi: 10.1016/S0091-6749(99)70107-7 – volume: 75 issue: 10 year: 2021 ident: 10.1016/j.waojou.2024.100944_bib32 article-title: Prognostic value of neutrophil-lymphocyte ratio in cardiogenic shock complicating acute myocardial infarction: a cohort study publication-title: Int J Clin Pract doi: 10.1111/ijcp.14655 – volume: 12 start-page: 6903 issue: 21 year: 2023 ident: 10.1016/j.waojou.2024.100944_bib31 article-title: The prognostic role of platelet-to-lymphocyte ratio in acute coronary syndromes: a systematic review and meta-analysis publication-title: J Clin Med – volume: 2022 year: 2022 ident: 10.1016/j.waojou.2024.100944_bib35 article-title: Prognostic value of platelet to lymphocyte ratio in sepsis: a systematic review and meta-analysis publication-title: BioMed Res Int – volume: 22 start-page: 332 issue: 4 year: 2022 ident: 10.1016/j.waojou.2024.100944_bib4 article-title: Emergency treatment of anaphylaxis: concise clinical guidance publication-title: Clin Med doi: 10.7861/clinmed.2022-0073 – volume: 49 start-page: 976 issue: 5 year: 2023 ident: 10.1016/j.waojou.2024.100944_bib14 article-title: Platelet-activating factor as an endogenous cofactor of food anaphylaxis publication-title: Biofactors doi: 10.1002/biof.1956 – volume: 68 start-page: 50 year: 2022 ident: 10.1016/j.waojou.2024.100944_bib30 article-title: Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity publication-title: J Crit Care doi: 10.1016/j.jcrc.2021.12.005 – volume: 114 start-page: 371 issue: 2 year: 2004 ident: 10.1016/j.waojou.2024.100944_bib10 article-title: Clinical features and severity grading of anaphylaxis publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2004.04.029 – volume: 40 start-page: 235 issue: 5 year: 2022 ident: 10.1016/j.waojou.2024.100944_bib34 article-title: Association between neutrophil-to-lymphocyte ratio in the first seven days of sepsis and mortality publication-title: Enferm Infecc Microbiol Clín doi: 10.1016/j.eimc.2020.11.004 – volume: 45 start-page: 1027 issue: 6 year: 2015 ident: 10.1016/j.waojou.2024.100944_bib2 article-title: Epidemiology of anaphylaxis publication-title: Clin Exp Allergy doi: 10.1111/cea.12418 – volume: 181 start-page: 774 issue: 10 year: 2020 ident: 10.1016/j.waojou.2024.100944_bib8 article-title: Eosinophil/Neutrophil/Platelet-to-Lymphocyte ratios in various types of immediate hypersensitivity to NSAIDs: a preliminary study publication-title: Int Arch Allergy Immunol doi: 10.1159/000509116 – volume: 12 issue: 10 year: 2019 ident: 10.1016/j.waojou.2024.100944_bib9 article-title: Time to revisit the definition and clinical criteria for anaphylaxis? publication-title: World Allergy Organization Journal doi: 10.1016/j.waojou.2019.100066 – volume: 8 start-page: 1169 issue: 4 year: 2020 ident: 10.1016/j.waojou.2024.100944_bib3 article-title: Global trends in anaphylaxis epidemiology and clinical implications publication-title: J Allergy Clin Immunol Pract doi: 10.1016/j.jaip.2019.11.027 – volume: 276 start-page: 3383 issue: 12 year: 2019 ident: 10.1016/j.waojou.2024.100944_bib7 article-title: The association of allergic rhinitis severity with neutrophil–lymphocyte and platelet–lymphocyte ratio in adults publication-title: Eur Arch Oto-Rhino-Laryngol doi: 10.1007/s00405-019-05640-0 – volume: 67 start-page: 691 issue: 5 year: 2012 ident: 10.1016/j.waojou.2024.100944_bib25 article-title: Symptom profile and risk factors of anaphylaxis in Central Europe publication-title: Allergy doi: 10.1111/j.1398-9995.2012.02795.x – volume: 47 start-page: 361 issue: 3 year: 2017 ident: 10.1016/j.waojou.2024.100944_bib26 article-title: Neutrophil activation during acute human anaphylaxis: analysis of MPO and sCD62L publication-title: Clin Exp Allergy doi: 10.1111/cea.12868 – volume: 136 start-page: 1425 issue: 5 year: 2015 ident: 10.1016/j.waojou.2024.100944_bib29 article-title: Impact of sex on anaphylaxis severity—data from the Anaphylaxis Registry publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2015.06.052 – volume: 335 start-page: 624 issue: 7621 year: 2007 ident: 10.1016/j.waojou.2024.100944_bib11 article-title: The declaration of Helsinki publication-title: BMJ doi: 10.1136/bmj.39339.610000.BE – volume: 140 start-page: 335 issue: 2 year: 2017 ident: 10.1016/j.waojou.2024.100944_bib23 article-title: The pathophysiology of anaphylaxis publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2017.06.003 – volume: 94 start-page: 643 issue: 4 year: 2013 ident: 10.1016/j.waojou.2024.100944_bib24 article-title: Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions publication-title: J Leukoc Biol doi: 10.1189/jlb.1212623 – volume: 20 start-page: 383 issue: 6 year: 1999 ident: 10.1016/j.waojou.2024.100944_bib13 article-title: A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed? publication-title: Allergy Asthma Proc doi: 10.2500/108854199778251834 – volume: 16 start-page: 811 issue: 10 year: 2014 ident: 10.1016/j.waojou.2024.100944_bib16 article-title: Balance of apoptotic cell death and survival in allergic diseases publication-title: Microb Infect doi: 10.1016/j.micinf.2014.07.004 – volume: 24 start-page: 11719 issue: 22 year: 2020 ident: 10.1016/j.waojou.2024.100944_bib20 article-title: The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: a systematic review and meta-analysis publication-title: Eur Rev Med Pharmacol Sci – volume: 10 start-page: 75 issue: 1 year: 2021 ident: 10.1016/j.waojou.2024.100944_bib33 article-title: Neutrophil to lymphocyte ratio (NLR)-A useful tool for the prognosis of sepsis in the ICU publication-title: Biomedicines doi: 10.3390/biomedicines10010075 – volume: 135 start-page: 1424 issue: 6 year: 2015 ident: 10.1016/j.waojou.2024.100944_bib17 article-title: Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2015.04.019 – year: 2017 ident: 10.1016/j.waojou.2024.100944_bib12 – volume: 122 start-page: 337 issue: 3 year: 2019 ident: 10.1016/j.waojou.2024.100944_bib27 article-title: Neutrophil-to-lymphocyte ratio as a novel independent predictor of severe exacerbation in patients with asthma publication-title: Ann Allergy Asthma Immunol doi: 10.1016/j.anai.2018.11.029 – volume: 131 start-page: 144 issue: 1 year: 2013 ident: 10.1016/j.waojou.2024.100944_bib19 article-title: Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.08.016 – volume: 2015 year: 2015 ident: 10.1016/j.waojou.2024.100944_bib21 article-title: Clinical characteristics of inpatients with anaphylaxis in China publication-title: BioMed Res Int doi: 10.1155/2015/429534 – volume: 13 issue: 10 year: 2020 ident: 10.1016/j.waojou.2024.100944_bib1 article-title: World allergy organization anaphylaxis guidance 2020 publication-title: World Allergy Organization Journal doi: 10.1016/j.waojou.2020.100472 – volume: 17 start-page: 158 issue: 3 year: 2021 ident: 10.1016/j.waojou.2024.100944_bib5 article-title: The association between neutrophil-to-lymphocyte ratio and anaphylaxis refractory to epinephrine treatment publication-title: Signa Vitae – volume: 17 start-page: 16 issue: 1 year: 2021 ident: 10.1016/j.waojou.2024.100944_bib6 article-title: Can eosinophilia and neutrophil–lymphocyte ratio predict hospitalization in asthma exacerbation? Allergy publication-title: Asthma & Clinical Immunology doi: 10.1186/s13223-021-00512-x – volume: 67 start-page: 96 issue: 1 year: 2018 ident: 10.1016/j.waojou.2024.100944_bib22 article-title: Different clinical features of anaphylaxis according to cause and risk factors for severe reactions publication-title: Allergol Int doi: 10.1016/j.alit.2017.05.005 – volume: 8 start-page: 345 issue: 11 year: 1987 ident: 10.1016/j.waojou.2024.100944_bib18 article-title: Platelet-activating factor and cellular immune responses publication-title: Immunol Today doi: 10.1016/0167-5699(87)90010-7 – volume: 97 start-page: 39 issue: 1 year: 2006 ident: 10.1016/j.waojou.2024.100944_bib28 article-title: Anaphylaxis: a review of 601 cases publication-title: Ann Allergy Asthma Immunol doi: 10.1016/S1081-1206(10)61367-1 |
SSID | ssj0060153 |
Score | 2.3306003 |
Snippet | Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate intramuscular (IM)... Background Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate... Background: Refractory anaphylaxis poses an ongoing, lethal hypersensitivity response that unpredictably involves multiple organs despite appropriate... |
SourceID | doaj unpaywall proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 100944 |
SubjectTerms | Adrenaline Airway management Allergens Allergies Anaphylaxis Blood platelets Blood pressure Blood tests Cross-sectional studies Histamine Hypotension Laboratories Leukocytes Lymphocytes Mortality Neutrophil-to-lymphocyte ratio Neutrophils Ostomy Patients Platelet-to-lymphocyte ratio Refractory anaphylaxis Regression analysis Urticaria |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlhz4OJX07SYsLvaqNXrZ8TENCKKT00EBuQpZG7RZjL7te0v33HVm2SWhhc-jV1siyvpHmGzSaIeRDBZVETyNQqCynuBKBavTBaBW8tOC9rIe0i5dfi4sr-eVaXd8q9RVjwlJ64DRxn7SCYxYUd8EK6XmpHUNaUHsodFkKP1zzRTM2OVNpD0YvQ4npotwQzXVjOwQH_UEuY2BAJeUdQzTk679jj_7mm0_Io027tNsb2zS3bND5Pnk6ksf8JA36GXkA7XPy8HI8Hn9BfnxrkDoiErTvaLNFoDq37SEfUM5t6_MWNv2qW_5cNP9uss6Xq9hdrMGTdyHHYa-GijxbFI-prRv7e7F-Sa7Oz76fXtCxkgJ1SqmeMohmyBeeQeAVLjvHnKt9WdYVq8tjZi2HgI8Ek75UgfEiVGi5tdCl9gFAvCJ7bdfCG5KzQnEVOA_CF9I6jaAW6AUBYoD9WZERMU2rcWOa8VjtojFTPNkvk8AwEQyTwMgInaWWKc3GjvafI2Jz25gke3iAqmNG1TG7VCcjasLbTPdQcefEjhY7Pl7OciNPSfzjHpJHk1qZca9YG2RwSMIj98vI-_k1rvJ4dGNb6DbYBom8Rq7IcNCvkzrO_44Ml8cD6ox8nPXzXpN48D8m8ZA8jl2mmMgjstevNvAWeVpfvxuW5B92qjta priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VIvE4IN4NFBQkxM1V7diJc0AIEFWFtIgDK_VmObHdLoqSNJtVm3_fcV5QUdS9Oh7b8cx4vtHYMwDvU5ty9DQcsalmBDXREok-GEmd4doaw7M-7eLiR3y85N9PxMkOTIH2cQPXN7p2vp7UsikOLs-7T6jwH__c1brQFVKit8e4D_unnH-oz4kvLeVDsGOdjTtwF80V86K_4HOoAR2SPlUlApmUcMQP0_u6_wx8zX71af6vmbF_YepDuL8pa91d6KL4y3QdPYZHI-YMPw9C8gR2bPkU7i3GqPozOP1ZIOJEBpK2IkWH_K3yrrVhLxyhLk1Y2k3bVPXZqri5yzqsGz-cL90TVi7EZTd9IZ8OyX1G7EJfrtbPYXn07dfXYzIWYCC5EKIl1HrrZWJDrWMpamtO8zwzSZKlNEsOqdbMOmyKKDeJcJTFLkWDLyOZSOOsjV7AblmVdg9CGgsmHGMuMjHXuURZiNF5sohAcDwdBRBN26ryMTu5L5JRqOka2m81MEN5ZqiBGQGQmaoesnPc0v-L59jc1-fW7huq5lSNqqqksIfUCZY7HXHDEpl74szYWCZJZGQAYuK3mp6v4oGLA61umTyZ6UZ4M8CWLSj3J7FSk4YoBH6I3T1kDODd_BkPBx_x0aWtNtgH8b9EiElx0S8HcZz_HYEx83HtAA5m-dxqE19tMd1reOAphpuS-7DbNhv7BtFbm73tte8KyuhDeQ priority: 102 providerName: Scholars Portal |
Title | Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of refractory anaphylaxis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1939455124000759 https://dx.doi.org/10.1016/j.waojou.2024.100944 https://www.ncbi.nlm.nih.gov/pubmed/39220464 https://www.proquest.com/docview/3179770066 https://www.proquest.com/docview/3099858418 https://doi.org/10.1016/j.waojou.2024.100944 https://doaj.org/article/85e01f52cfa34d278c1009bde68773d8 |
UnpaywallVersion | publishedVersion |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: RBZ dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: KQ8 dateStart: 20080101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources (selected full-text only) customDbUrl: eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: AKRWK dateStart: 20080101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1939-4551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: RPM dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1939-4551 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0060153 issn: 1939-4551 databaseCode: M48 dateStart: 20080101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrQTiwPsRVKogccSrxrET59giqgppqwqxUuFiOX7QhShZ7SYqy69nnJdYHupyycGZcezx2PNNxh4DvM5sxtDTcMRmihKciZYI9MFI5gxT1hiWt2kXZ-fJ2Zy9v-SXe_BmOAuzFb9v92FdqwrFip4cZT6knzF2C_YTH06awP78_OL4Uxc4zghD6z-cjvsH65b1aZP0bxmhP0HmXbjTlEu1uVZF8YvhOb0Ps6HJ3X6Tb9Omzqf6x2_ZHHft0wO41yPQ8LhTmYewZ8tHcHvWx9gfw5eLAvEnDiepK1JscLQrvalt2KpKqEoTlrapV9XyalH8nWQdLle-On-RT1i5EMWwaq_12SC7z49dqO-L9ROYn777-PaM9NcxEM05r0lkvS0ziYmsoxnOXR1pnZs0zbMoT48ipah1WBRHzKTcRTRxGZp_EYtUGGdt_BQmZVXa5xBGCafcUepikzClBWpGgq6URTyC9ak4gHgYJqn7XOX-yoxCDpvSvspOhtLLUHYyDICMXMsuV8cN9CdeA0Zan2m7LcDBkv3ElYLbo8hxqp2KmaGp0J45NzYRaRobEQAf9EcOh1lx-cWKFjd8PB35erDTgZgdOA8GNZX9grOWCAMRyXsAGcCr8TUuFT7-o0pbNUiD3oBAwBlho5916j32HWEy9VHuAKajvu8kxBf_y3AAk3rV2JeI5er8sP0Hgs8ZE_j8cPL5sJ_UPwFpr0pF |
linkProvider | Unpaywall |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrQTiwPuxqKAgccSr2rET51gQVYW0VQ-sVE6W4wdsiZLVbqKy_HrGeYnloS5XZ8axxzOebzT2GOBN5jKOkYYnLtOMoCU6IjEGI5m3XDtred6WXZyfJ2cL_vFSXB7A2-EuzE7-vj2Hda0rFCtGcoyHlH7G-S04TEI6aQKHi_OLk89d4jgjHL3_cDvuH6w73qct0r_jhP4EmXfhTlOu9PZaF8Uvjuf0PsyHIXfnTb7NmjqfmR-_VXPcd04P4F6PQKOTTmUewoErH8HteZ9jfwxfLgrEn7icpK5IscXVrsy2dlGrKpEubVS6pl5Xq6_L4u8km2i1Dt2Fh3yiykcohnX7rM8W2UN97EJ_X26ewOL0w6f3Z6R_joEYIURNqAu-zCaWOs8ytF1DjcltmuYZzdNjqjVzHptiym0qPGWJz9D9y1im0nrn4qcwKavSPYeIJoIJz5iPbcK1kagZCYZSDvEI9qfjKcTDMinT1yoPT2YUajiUdqU6GaogQ9XJcApk5Fp1tTpuoH8XNGCkDZW22wZcLNUbrpLCHVMvmPE65pal0gTm3LpEpmls5RTEoD9quMyK2y92tLzh5-nI14OdDsTswXk0qKnqN5yNQhiISD4AyCm8Hj_jVhHyP7p0VYM0GA1IBJwUB_2sU-9x7giTWchyT2E26vteQnzxvwxHMKnXjXuJWK7OX_Um_BNTuEdn |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelet-to-lymphocyte+ratio+and+neutrophil-to-lymphocyte+ratio+as+predictors+of+refractory+anaphylaxis&rft.jtitle=The+World+Allergy+Organization+journal&rft.au=Nghi%2C+Le+Vinh&rft.au=Phuc%2C+Nguyen+Hoang&rft.au=Hai%2C+Pham+Dang&rft.date=2024-08-01&rft.issn=1939-4551&rft.eissn=1939-4551&rft.volume=17&rft.issue=8&rft.spage=100944&rft_id=info:doi/10.1016%2Fj.waojou.2024.100944&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1939-4551&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1939-4551&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1939-4551&client=summon |